Transabdominal Ultrasound With BR55 for Characterization of Pancreatic Lesions

Summary

This is an exploratory, single center, open label, parallel-dose, and prospective study of BR55 contrast-enhanced ultrasonography (CEUS) for characterization of solid pancreatic lesions in subjects with suspected pancreatic ductal adenocarcinoma (PDAC) using transabdominal US.

Timeline

Start

2018-07-19

Primary completion

2020-11-13

Completion

2021-07-31

Outcome

Outcome not reported

Stopped (Enrollment): “Sponsor decision; expiration of available study agent due to long recruitment timeline.”

Drugs

Indications